These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 27230555

  • 21. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Feng X, Wu H, Grossman JM, Hanvivadhanakul P, FitzGerald JD, Park GS, Dong X, Chen W, Kim MH, Weng HH, Furst DE, Gorn A, McMahon M, Taylor M, Brahn E, Hahn BH, Tsao BP.
    Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
    [Abstract] [Full Text] [Related]

  • 22. Constitutive phosphorylation of interferon receptor A-associated signaling proteins in systemic lupus erythematosus.
    Ramírez-Vélez G, Medina F, Ramírez-Montaño L, Zarazúa-Lozada A, Hernández R, Llorente L, Moreno J.
    PLoS One; 2012 Sep; 7(7):e41414. PubMed ID: 22859983
    [Abstract] [Full Text] [Related]

  • 23. Anti-interferon alpha treatment in SLE.
    Kirou KA, Gkrouzman E.
    Clin Immunol; 2013 Sep; 148(3):303-12. PubMed ID: 23566912
    [Abstract] [Full Text] [Related]

  • 24. Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.
    Bilsborrow JB, Doherty E, Tilstam PV, Bucala R.
    Expert Opin Ther Targets; 2019 Sep; 23(9):733-744. PubMed ID: 31414920
    [Abstract] [Full Text] [Related]

  • 25. [Interferon-α mediating the functional damage of CD56dimCD57+natural killer cells in peripheral blood of systemic lupus erythematosuss].
    Zhao XG, Liu JQ, Huang HN, Lu ZM, Bai ZR, Li X, Qi JJ.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec 18; 55(6):975-981. PubMed ID: 38101777
    [Abstract] [Full Text] [Related]

  • 26. Toll-like receptor 9 is correlated to disease activity in Chinese systemic lupus erythematosus population.
    Mu R, Sun XY, Lim LT, Xu CH, Dai CX, Su Y, Jia RL, Li ZG.
    Chin Med J (Engl); 2012 Aug 18; 125(16):2873-7. PubMed ID: 22932083
    [Abstract] [Full Text] [Related]

  • 27. The small molecule macrophage migration inhibitory factor antagonist MIF098, inhibits pulmonary hypertension associated with murine SLE.
    Huang H, Chen D, Pu J, Yuan A, Fu Q, Li J, Leng L, Bucala R, Ye S, Lu L.
    Int Immunopharmacol; 2019 Nov 18; 76():105874. PubMed ID: 31499270
    [Abstract] [Full Text] [Related]

  • 28. Activation of JAK-STAT1 signal transduction pathway in lesional skin and monocytes from patients with systemic lupus erythematosus.
    Li J, Zhao S, Yi M, Hu X, Li J, Xie H, Zhu W, Chen M.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Feb 18; 36(2):109-15. PubMed ID: 21368418
    [Abstract] [Full Text] [Related]

  • 29. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
    Liu M, Liu J, Hao S, Wu P, Zhang X, Xiao Y, Jiang G, Huang X.
    Clin Rheumatol; 2018 Oct 18; 37(10):2675-2684. PubMed ID: 29774490
    [Abstract] [Full Text] [Related]

  • 30. Circulating macrophage migration inhibitory factor levels and its polymorphisms in systemic lupus erythematosus: A meta-analysis.
    Bae SC, Lee YH.
    Cell Mol Biol (Noisy-le-grand); 2017 Oct 31; 63(10):74-79. PubMed ID: 29096759
    [Abstract] [Full Text] [Related]

  • 31. The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-γ production in T cells from patients with SLE.
    Hagberg N, Joelsson M, Leonard D, Reid S, Eloranta ML, Mo J, Nilsson MK, Syvänen AC, Bryceson YT, Rönnblom L.
    Ann Rheum Dis; 2018 Jul 31; 77(7):1070-1077. PubMed ID: 29475858
    [Abstract] [Full Text] [Related]

  • 32. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK.
    Arthritis Rheum; 2005 May 31; 52(5):1491-503. PubMed ID: 15880830
    [Abstract] [Full Text] [Related]

  • 33. Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.
    Wirestam L, Enocsson H, Skogh T, Eloranta ML, Rönnblom L, Sjöwall C, Wetterö J.
    Clin Exp Immunol; 2017 Jul 31; 189(1):83-91. PubMed ID: 28257596
    [Abstract] [Full Text] [Related]

  • 34. Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis.
    Du Y, Wu X, Chen M, Wang W, Xv W, Ye L, Wu D, Xue J, Sun W, Luo J, Wu H.
    Clin Exp Immunol; 2017 May 31; 188(2):234-242. PubMed ID: 28063160
    [Abstract] [Full Text] [Related]

  • 35. [The expression of macrophage migration inhibitory factor in obstructive sleep apnea hypopnea syndrome and its injury to endothelial cells].
    Yuan P, Wang WJ, Li DF, Ou Q, Gao XL.
    Zhonghua Jie He He Hu Xi Za Zhi; 2016 Nov 12; 39(11):871-875. PubMed ID: 27852364
    [Abstract] [Full Text] [Related]

  • 36. [EFFECT OF MACROPHAGE MIGRATION INHIBITORY FACTOR ON VASCULAR REPAIR OF STEROID-INDUCED AVASCULAR NECROSIS OF FEMORAL HEAD IN VITRO].
    Ma J, Zhang C, Zhang E, Ban W, Lü L, Dang X, Wang K.
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2016 Aug 08; 30(8):998-1005. PubMed ID: 29786232
    [Abstract] [Full Text] [Related]

  • 37. Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus.
    Connelly KL, Kandane-Rathnayake R, Hoi A, Nikpour M, Morand EF.
    Sci Rep; 2016 Jul 25; 6():29909. PubMed ID: 27453287
    [Abstract] [Full Text] [Related]

  • 38. Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus.
    Li Y, Lee PY, Kellner ES, Paulus M, Switanek J, Xu Y, Zhuang H, Sobel ES, Segal MS, Satoh M, Reeves WH.
    Arthritis Res Ther; 2010 Jul 25; 12(3):R90. PubMed ID: 20478071
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of TLR9 expression on PBMCs and CpG ODN-TLR9 ligation on IFN-α production in SLE patients.
    Mortezagholi S, Babaloo Z, Rahimzadeh P, Namdari H, Ghaedi M, Gharibdoost F, Mirzaei R, Bidad K, Salehi E.
    Immunopharmacol Immunotoxicol; 2017 Feb 25; 39(1):11-18. PubMed ID: 28049380
    [Abstract] [Full Text] [Related]

  • 40. Potential role of RhoA GTPase regulation in type interferon signaling in systemic lupus erythematosus.
    Fan W, Wei B, Chen X, Zhang Y, Xiao P, Li K, Zhang YQ, Huang J, Leng L, Bucala R.
    Arthritis Res Ther; 2024 Jan 20; 26(1):31. PubMed ID: 38243295
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.